QR-kod

Economic and Clinical Benefits of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for Prevention of RSV in Infants: A Cost-Effectiveness Analysis for Mexico

Background/Objectives: Respiratory syncytial virus (RSV) is a leading cause of respiratory infections in children. A novel RSVpreF vaccine for use among pregnant women for the prevention of RSV in infants is expected to be licensed in Mexico. Hence, the clinical and economic burden of RSV among infa...

Full beskrivning

Sparad:
Huvudupphov: José Luis Huerta, Robyn Kendall, Luka Ivkovic, Carlos Molina, Amy W. Law, Diana Mendes
Materialtyp: Artigo
Språk:Inglês
Utgiven: MDPI AG 2025-01-01
Serie:Vaccines
Ämnen:
cost-effectiveness
respiratory syncytial virus (RSV)
RSVpreF vaccine
maternal immunization
Mexico
economic evaluation
Länkar:https://www.mdpi.com/2076-393X/13/1/77
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk